Susan P. Stimson, Chief Strategy Officer at Intersect ENT, Inc. (XENT), sold 350 shares at $25.00 ($9K) on 2019-06-13, disclosed to the SEC on 2019-06-17.
Scheduled sale ($9k) by Chief Strategy Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| XENT | SELL | 2019-04-24 | $80K | — | Filing → |
| XENT | SELL | 2019-04-12 | $291K | — | Filing → |